What is RAF-265 used for?

RAF-265 is being researched for the treatment of metastatic melanoma and other types of tumors (neoplasms).

Is RAF-265 approved for use?

No, RAF-265 is currently an investigational drug in clinical trials and has not received full approval.

What kind of drug is RAF-265?

RAF-265 is classified as a small molecule drug.

Is RAF-265 safe for children?

Information regarding the safety of RAF-265 in pediatric patients is not available in the current data.

Can I take RAF-265 with other medicines?

There is currently no information available regarding how RAF-265 interacts with other drugs.

What are the side effects of RAF-265?

The provided data does not list specific side effects for RAF-265 at this time.

RAF265 | CAS 927880-90-8 | YABJJWZLRMPFSI

Loading compound...

Small molecule kinase inhibitor (investigational)

RAF-265 is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat certain types of cancer, such as metastatic melanoma and other neoplasms.

How it worksRAF-265 is a small molecule designed to target specific biological pathways related to cancer growth.

Used for

metastatic melanomaneoplasms

Conditions

metastatic melanomaneoplasm

Class

Small moleculeSmall molecule kinase inhibitor (investigational)

How to take

This drug is currently in the investigational phase (max phase 2) and is not yet FDA-approved for general use.

Talk to your doctor

Questions to ask

·Is RAF-265 appropriate for my specific type of cancer?
·What stage of clinical trials is RAF-265 currently in?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)